396 related articles for article (PubMed ID: 10233258)
1. Keratinocytes suppress transforming growth factor-beta1 expression by fibroblasts in cultured skin substitutes.
Le Poole IC; Boyce ST
Br J Dermatol; 1999 Mar; 140(3):409-16. PubMed ID: 10233258
[TBL] [Abstract][Full Text] [Related]
2. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
Ghahary A; Tredget EE; Shen Q
J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of melanoma-associated growth factors in keratinocytes and fibroblasts by ultraviolet A and ultraviolet B radiation.
Brenner M; Degitz K; Besch R; Berking C
Br J Dermatol; 2005 Oct; 153(4):733-9. PubMed ID: 16181453
[TBL] [Abstract][Full Text] [Related]
4. Keratinocyte differentiation inversely regulates the expression of involucrin and transforming growth factor beta1.
Ghahary A; Marcoux Y; Karimi-Busheri F; Tredget EE
J Cell Biochem; 2001 Aug 1-9; 83(2):239-48. PubMed ID: 11573241
[TBL] [Abstract][Full Text] [Related]
5. Proteolytic and non-proteolytic activation of keratinocyte-derived latent TGF-β1 induces fibroblast differentiation in a wound-healing model using rat skin.
Hata S; Okamura K; Hatta M; Ishikawa H; Yamazaki J
J Pharmacol Sci; 2014; 124(2):230-43. PubMed ID: 24492413
[TBL] [Abstract][Full Text] [Related]
6. Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids.
Amano S; Akutsu N; Ogura Y; Nishiyama T
Br J Dermatol; 2004 Nov; 151(5):961-70. PubMed ID: 15541073
[TBL] [Abstract][Full Text] [Related]
7. Development, characterization, and wound healing of the keratin 14 promoted transforming growth factor-beta1 transgenic mouse.
Chan T; Ghahary A; Demare J; Yang L; Iwashina T; Scott PG; Tredget EE
Wound Repair Regen; 2002; 10(3):177-87. PubMed ID: 12100379
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of tumor suppressor protein neurofibromin in normal human wound healing and in vitro evidence for platelet derived growth factor (PDGF) and transforming growth factor-beta1 (TGF-beta1) elicited increase in neurofibromin mRNA steady-state levels in dermal fibroblasts.
Ylä-Outinen H; Aaltonen V; Björkstrand AS; Hirvonen O; Lakkakorpi J; Vähä-Kreula M; Laato M; Peltonen J
J Invest Dermatol; 1998 Mar; 110(3):232-7. PubMed ID: 9506441
[TBL] [Abstract][Full Text] [Related]
9. Genetically modified dermal keratinocytes express high levels of transforming growth factor-beta1.
Ghahary A; Tredget EE; Chang LJ; Scott PG; Shen Q
J Invest Dermatol; 1998 May; 110(5):800-5. PubMed ID: 9579549
[TBL] [Abstract][Full Text] [Related]
10. Keratinocyte regulation of TGF-beta and connective tissue growth factor expression: a role in suppression of scar tissue formation.
Amjad SB; Carachi R; Edward M
Wound Repair Regen; 2007; 15(5):748-55. PubMed ID: 17971021
[TBL] [Abstract][Full Text] [Related]
11. Complex epithelial-mesenchymal interactions modulate transforming growth factor-beta expression in keloid-derived cells.
Xia W; Phan TT; Lim IJ; Longaker MT; Yang GP
Wound Repair Regen; 2004; 12(5):546-56. PubMed ID: 15453837
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo.
Tredget EE; Wang R; Shen Q; Scott PG; Ghahary A
J Interferon Cytokine Res; 2000 Feb; 20(2):143-51. PubMed ID: 10714549
[TBL] [Abstract][Full Text] [Related]
13. Induction of PDGF-B in TCA-treated epidermal keratinocytes.
Yonei N; Kanazawa N; Ohtani T; Furukawa F; Yamamoto Y
Arch Dermatol Res; 2007 Nov; 299(9):433-40. PubMed ID: 17724602
[TBL] [Abstract][Full Text] [Related]
14. Keratinocyte conditioned medium abrogates the modulatory effects of IGF-1 and TGF-beta1 on collagenase expression in dermal fibroblasts.
Kilani RT; Guilbert L; Lin X; Ghahary A
Wound Repair Regen; 2007; 15(2):236-44. PubMed ID: 17352756
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic scar tissues and fibroblasts produce more transforming growth factor-beta1 mRNA and protein than normal skin and cells.
Wang R; Ghahary A; Shen Q; Scott PG; Roy K; Tredget EE
Wound Repair Regen; 2000; 8(2):128-37. PubMed ID: 10810039
[TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor-beta promotes deposition of collagen VII in a modified organotypic skin model.
König A; Bruckner-Tuderman L
Lab Invest; 1994 Feb; 70(2):203-9. PubMed ID: 8139261
[TBL] [Abstract][Full Text] [Related]
17. Dermal fibroblasts are one of the therapeutic targets for topical application of 1alpha,25-dihydroxyvitamin D3: the possible involvement of transforming growth factor-beta induction.
Oyama N; Iwatsuki K; Satoh M; Akiba H; Kaneko F
Br J Dermatol; 2000 Dec; 143(6):1140-8. PubMed ID: 11122013
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2).
Strutz F; Zeisberg M; Renziehausen A; Raschke B; Becker V; van Kooten C; Müller G
Kidney Int; 2001 Feb; 59(2):579-92. PubMed ID: 11168939
[TBL] [Abstract][Full Text] [Related]
19. Latent and active transforming growth factor beta1 released from genetically modified keratinocytes modulates extracellular matrix expression by dermal fibroblasts in a coculture system.
Bauer BS; Tredget EE; Marcoux Y; Scott PG; Ghahary A
J Invest Dermatol; 2002 Aug; 119(2):456-63. PubMed ID: 12190870
[TBL] [Abstract][Full Text] [Related]
20. Dissecting the roles of endothelin, TGF-beta and GM-CSF on myofibroblast differentiation by keratinocytes.
Shephard P; Hinz B; Smola-Hess S; Meister JJ; Krieg T; Smola H
Thromb Haemost; 2004 Aug; 92(2):262-74. PubMed ID: 15269821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
